1. Home
  2. NTNX vs DGX Comparison

NTNX vs DGX Comparison

Compare NTNX & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutanix Inc.

NTNX

Nutanix Inc.

HOLD

Current Price

$47.17

Market Cap

20.5B

Sector

Technology

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$182.89

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTNX
DGX
Founded
2009
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.5B
20.5B
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
NTNX
DGX
Price
$47.17
$182.89
Analyst Decision
Buy
Buy
Analyst Count
16
15
Target Price
$76.20
$194.07
AVG Volume (30 Days)
4.9M
1.2M
Earning Date
11-25-2025
10-21-2025
Dividend Yield
N/A
1.75%
EPS Growth
N/A
14.49
EPS
0.76
8.51
Revenue
$2,617,547,000.00
$10,850,000,000.00
Revenue This Year
$15.92
$12.37
Revenue Next Year
$13.80
$3.52
P/E Ratio
$62.39
$21.44
Revenue Growth
17.45
13.74
52 Week Low
$46.12
$148.70
52 Week High
$83.36
$197.55

Technical Indicators

Market Signals
Indicator
NTNX
DGX
Relative Strength Index (RSI) 19.87 44.87
Support Level $46.12 $184.18
Resistance Level $48.19 $185.12
Average True Range (ATR) 1.92 3.22
MACD -1.08 -0.78
Stochastic Oscillator 6.19 3.85

Price Performance

Historical Comparison
NTNX
DGX

About NTNX Nutanix Inc.

Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data, anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company is into a single operating and reportable segment that is subscription-based business model. Key revenue is generated from United States.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: